Alphabet Inc. — 13F Holdings & Portfolio
CIK 1652044 · latest 13F-HR filed 2026-08-07
Alphabet Inc. manages $99.08B in 13F-reported U.S. long-equity assets across 29 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SPCX (95.05%), PL (1.18%), ASTS (0.80%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 3 new positions and exited 1; 16 existing positions rose in reported value and 7 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-07
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
| Name | Title / Status | Ownership | Type |
|---|
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- ARM HOLDINGS PLC$398.6M +134.4%
- REVOLUTION MEDICINES INC$231.6M +72.3%
- PLANET LABS PBC$182.6M +18.5%
- AST SPACEMOBILE INC$53.6M +7.2%
- FRESHWORKS INC$33.9M +26.0%
Top Trims
- CME GROUP INC-$259.6M -25.2%
- PAYPAY CORP-$21.9M -32.8%
- BRIDGEBIO ONCOLOGY THERAPEUT-$3.8M -14.9%
- MONTE ROSA THERAPEUTICS INC-$2.2M -19.9%
- LYELL IMMUNOPHARMA INC-$1.8M -30.0%
New Positions
- SPACE EXPLORATION TECHN CORP$94.18B
- PARABILIS MEDICINES INC$134.6M
- FERVO ENERGY CO$51.5M
Alphabet Inc. Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | SPACE EXPLORATION TECHN CORP | SPCX | 84615Q103 | $94.18B | 95.05% | 551,189,500 | SH |
| 2 | PLANET LABS PBC | PL | 72703X106 | $1.17B | 1.18% | 35,248,893 | SH |
| 3 | AST SPACEMOBILE INC | ASTS | 00217D100 | $794.7M | 0.80% | 8,943,486 | SH |
| 4 | CME GROUP INC | CME | 12572Q105 | $769.4M | 0.78% | 3,484,020 | SH |
| 5 | ARM HOLDINGS PLC | ARM | 042068205 | $695.2M | 0.70% | 1,960,784 | SH |
| 6 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $551.8M | 0.56% | 2,946,619 | SH |
| 7 | FRESHWORKS INC | FRSH | 358054104 | $145.0M | 0.15% | 14,327,273 | SH |
| 8 | PARABILIS MEDICINES INC | PBLS | 698955101 | $134.6M | 0.14% | 4,919,498 | SH |
| 9 | TEMPUS AI INC | TEM | 88023B103 | $89.9M | 0.09% | 1,551,102 | SH |
| 10 | GITLAB INC | GTLB | 37637K108 | $83.2M | 0.08% | 2,724,712 | SH |
| 11 | UIPATH INC | PATH | 90364P105 | $76.5M | 0.08% | 7,034,337 | SH |
| 12 | ETHOS TECHNOLOGIES INC | LIFE | 29765A101 | $65.7M | 0.07% | 3,622,604 | SH |
| 13 | PRIME MEDICINE INC | PRME | 74168J101 | $61.1M | 0.06% | 16,562,498 | SH |
| 14 | FERVO ENERGY CO | FRVO | 31556C106 | $51.5M | 0.05% | 1,760,732 | SH |
| 15 | PAYPAY CORP | PAYP | 70450C101 | $44.8M | 0.05% | 3,125,000 | SH |
| 16 | MAZE THERAPEUTICS INC | MAZE | 578784100 | $41.4M | 0.04% | 1,388,583 | SH |
| 17 | RELAY THERAPEUTICS INC | RLAY | 75943R102 | $26.4M | 0.03% | 1,410,029 | SH |
| 18 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 107924102 | $21.5M | 0.02% | 2,823,126 | SH |
| 19 | FRESHWORKS INC | FRSH | 358054104 | $19.0M | 0.02% | 1,879,370 | SH |
| 20 | OSCAR HEALTH INC | OSCR | 687793109 | $13.7M | 0.01% | 481,988 | SH |
| 21 | BEAM THERAPEUTICS INC | BEAM | 07373V105 | $11.0M | 0.01% | 321,604 | SH |
| 22 | VERA THERAPEUTICS INC | VERA | 92337R101 | $10.4M | 0.01% | 241,264 | SH |
| 23 | SANA BIOTECHNOLOGY INC | SANA | 799566104 | $9.8M | 0.01% | 2,812,500 | SH |
| 24 | MONTE ROSA THERAPEUTICS INC | GLUE | 61225M102 | $9.0M | 0.01% | 372,474 | SH |
| 25 | LYELL IMMUNOPHARMA INC | LYEL | 55083R203 | $4.1M | 0.00% | 293,256 | SH |
| 26 | FIGMA INC | FIG | 316841105 | $3.9M | 0.00% | 215,582 | SH |
| 27 | SPERO THERAPEUTICS INC | SPRO | 84833T103 | $2.0M | 0.00% | 889,979 | SH |
| 28 | HYPERFINE INC | HYPR | 44916K106 | $1.2M | 0.00% | 898,720 | SH |
| 29 | AUTOLUS THERAPEUTICS PLC | AUTL | 05280R100 | $1.1M | 0.00% | 698,262 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-07 | $99.08B | 29 | 0001652044-26-000073 |
| 2026-03-31 | 2026-05-08 | $4.02B | 27 | 0001652044-26-000051 |
| 2025-12-31 | 2026-02-13 | $2.58B | 32 | 0001652044-26-000023 |
MOUNTAIN VIEW, CA 94043